To test whether high Toca-1 levels correlated with clinical outcomes, we used the Kaplan-Meier Plotter analysis tool [40] to analyze Toca-1 transcript levels in breast cancer microarray datasets. The gene discussed is FNBP1L; the disease is breast cancer.